mephentermine has been researched along with Cerebrovascular Disorders in 1 studies
Mephentermine: A sympathomimetic agent with specificity for alpha-1 adrenergic receptors. It is used to maintain BLOOD PRESSURE in hypotensive states such as following SPINAL ANESTHESIA.
Cerebrovascular Disorders: A spectrum of pathological conditions of impaired blood flow in the brain. They can involve vessels (ARTERIES or VEINS) in the CEREBRUM, the CEREBELLUM, and the BRAIN STEM. Major categories include INTRACRANIAL ARTERIOVENOUS MALFORMATIONS; BRAIN ISCHEMIA; CEREBRAL HEMORRHAGE; and others.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| FAZEKAS, JF | 1 |
| ALMAN, RW | 1 |
1 other study available for mephentermine and Cerebrovascular Disorders
| Article | Year |
|---|---|
VASOPRESSOR AGENTS IN CEREBRAL VASCULAR INSUFFICIENCY.
Topics: Blood Circulation; Brain Ischemia; Cerebrovascular Disorders; Humans; Mephentermine; Vasoconstrictor | 1963 |